Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control
- PMID: 9069310
- DOI: 10.1016/s0360-3016(96)00497-x
Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control
Abstract
Purpose: This study aimed to analyze dose, initial pattern of enhancement, and other factors associated with freedom from progression (FFP) of brain metastases after radiosurgery (RS).
Methods and materials: All brain metastases treated with gamma-knife RS at the University of California, San Francisco, from 1991 to 1994 were reviewed. Evaluable lesions were those with follow-up magnetic resonance or computed tomographic imaging. Actuarial FFP was calculated using the Kaplan-Meier method, measuring FFP from the date of RS to the first imaging study showing tumor progression. Controlled lesions were censored at the time of the last imaging study. Multivariate analyses were performed using a stepwise Cox proportional hazards model.
Results: Of 261 lesions treated in 119 patients, 219 lesions in 100 patients were evaluable. Major histologies included adenocarcinoma (86 lesions), melanoma (77), renal cell carcinoma (21), and carcinoma not otherwise specified (17). The median prescribed RS dose was 18.5 Gy (range, 10-22) and the median tumor volume was 1.3 ml (range, 0.02-30.9). The initial pattern of contrast enhancement was homogeneous in 68% of lesions, heterogeneous in 12%, and ring-enhancing in 19%. The actuarial FFP was 82% at 6 months and 77% at 1 year for all lesions, and 93 and 90%, respectively, for 145 lesions receiving > or = 18 Gy. Multivariate analysis showed that longer FFP was significantly associated with higher prescribed RS dose, a homogeneous pattern of contrast enhancement, and a longer interval between primary diagnosis and RS. Adjusted for these factors, adenocarcinomas had longer FFP than melanomas. No significant differences in FFP were noted among lesions undergoing RS for recurrence after prior radiotherapy (119 lesions), RS alone as initial treatment (45), or RS boost (55).
Conclusion: A minimum prescribed radiosurgical dose > or = 18 Gy yields excellent local control of brain metastases. The influence of pattern of enhancement on local control, a new finding in this retrospective analysis, needs to be confirmed.
Similar articles
-
Relationship between pattern of enhancement and local control of brain metastases after radiosurgery.Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):139-46. doi: 10.1016/s0360-3016(00)01584-4. Int J Radiat Oncol Biol Phys. 2001. PMID: 11316557
-
Gamma knife radiosurgery for malignant melanoma brain metastases.Cancer J Sci Am. 1998 Mar-Apr;4(2):103-9. Cancer J Sci Am. 1998. PMID: 9532412
-
Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma.J Neurosurg. 2008 Dec;109 Suppl:122-8. doi: 10.3171/JNS/2008/109/12/S19. J Neurosurg. 2008. PMID: 19123898
-
[Importance of radiotherapy in stereotactic conditions (radiosurgery) in brain metastasis: experience and results of the Hôpital Pitié-Salpêtrière Group].Cancer Radiother. 1998 May-Jun;2(3):272-81. doi: 10.1016/s1278-3218(98)80005-x. Cancer Radiother. 1998. PMID: 9749126 Review. French.
-
Radiosurgery for the treatment of brain metastases in renal cell carcinoma.Anticancer Res. 1999 Mar-Apr;19(2C):1611-7. Anticancer Res. 1999. PMID: 10365156 Review.
Cited by
-
Comparison of two-stage Gamma Knife radiosurgery outcomes for large brain metastases among primary cancers.J Neurooncol. 2020 Mar;147(1):237-246. doi: 10.1007/s11060-020-03421-y. Epub 2020 Feb 5. J Neurooncol. 2020. PMID: 32026433
-
Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients.Front Oncol. 2023 Jun 30;13:1216852. doi: 10.3389/fonc.2023.1216852. eCollection 2023. Front Oncol. 2023. PMID: 37456254 Free PMC article.
-
HyperArc VMAT planning for single and multiple brain metastases stereotactic radiosurgery: a new treatment planning approach.Radiat Oncol. 2018 Jan 29;13(1):13. doi: 10.1186/s13014-017-0948-z. Radiat Oncol. 2018. PMID: 29378610 Free PMC article.
-
Recursive partitioning analysis for the prediction of stereotactic radiosurgery brain metastases lesion control.Oncologist. 2013;18(3):330-5. doi: 10.1634/theoncologist.2012-0316. Epub 2013 Feb 19. Oncologist. 2013. PMID: 23429647 Free PMC article.
-
Stereotactic Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques.Cancers (Basel). 2023 Nov 14;15(22):5404. doi: 10.3390/cancers15225404. Cancers (Basel). 2023. PMID: 38001664 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical